We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Prophotonix Limited | LSE:PPIX | London | Ordinary Share | COM SHS $0.001 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 8.75 | 8.50 | 9.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
14/7/2017 07:48 | I agree with greedy roosters comments earlier, I think the for sale sign is up and they are giving cheap shares to mates first. Will be sold shortly. | pauliewonder | |
14/7/2017 07:42 | POST REMOVED | buywell3 | |
14/7/2017 07:28 | Not the greatest trading statement. Lost a large customer...I did mention a while ago that some customers account for a large percentage of sales which is not a good position to be in. Paid off debt though, something I like to see. | dr biotech | |
14/7/2017 07:25 | POST REMOVED | buywell3 | |
07/7/2017 11:05 | Edging up again. Looks set to march on ahead of results. | greedy rooster | |
04/7/2017 08:08 | Strong statement from 600 Group this morning which will read well across for PPIX. | greedy rooster | |
29/6/2017 10:09 | POST REMOVED | buywell3 | |
29/6/2017 08:09 | All of this trumpeting of success convinces me that the 'For Sale' sign is being put up. | greedy rooster | |
27/6/2017 22:35 | Lots of $ earners hit...no chart support till 6p. Think I'll just continue to watch for now | dr biotech | |
27/6/2017 19:48 | POST REMOVED | buywell3 | |
27/6/2017 12:25 | Discussion group following the share price ...asleep | cezary | |
27/6/2017 12:23 | Discussion group gone to sleep just like share price | cezary | |
14/6/2017 08:23 | With expectations of 2c earnings for FY 17 the shares trade on 10x earnings. This is for a stock whose end markets are typically growing by 40% CAGR. The ability to gain access to fast growth at a 50% discount to market value should not be overlooked. After a period of strong performance an element of consolidation is inevitable but the fundamentals and outlook support a much higher share price.!FOLLOWFEED | greedy rooster | |
13/6/2017 17:48 | POST REMOVED | buywell3 | |
13/6/2017 10:59 | So two key markets are robotics and 3d printing/UV curing with the latter being in it's infancy. And yet we sit there unnoticed and trading on a cheap p/e versus a fully valued market with the prospect of some corporate activity within the next 3 months if the exercise price is to be achieved....not bad | greedy rooster | |
07/6/2017 11:19 | Healthy pull back in my mind, this remains an excellent opportunity with the chance of a upgrade to forecasts on next trading statement/results. | greedy rooster | |
07/6/2017 07:40 | The options would raise about £2m if all were exercised. That kind of cash would be very useful for a company of this size. | rcturner2 | |
07/6/2017 07:32 | POST REMOVED | buywell3 | |
07/6/2017 07:31 | It would be nice if we could see what the targets were. This should be compulsory for listed companies- obviously it's a wider issue than just for ppix. I don't see debt here as being an issue, so a rights is not particularly needed. Always the danger that they will sell the lot and pay for the options post sale. But hopefully they would only do this slowly over time. Some of he directors have decent stakes which is always good to see. One of the co's I hold has options set at 70p with the current share price is about 43 that's a much more challenging target and more aligned with shareholders interests. Unfortunately that seems to be the exception rather than the rule | dr biotech | |
07/6/2017 06:33 | DrB, the options listed are the maximum possible, based on actual company performance. So the directors will only receive that amount (which still have to be paid for and therefore work like a rights issue and raise money for the company) if the company performs very well. I much prefer out of the money options as many option schemes simply give free or low cost shares to directors for no improved performance. | rcturner2 | |
06/6/2017 23:08 | That's a lot of options they have potentially granted themselves. 16% of the company. Price isn't too challenging either before today's fall. | dr biotech | |
06/6/2017 09:47 | Excellent company. | someuwin | |
04/6/2017 09:40 | POST REMOVED | buywell3 | |
04/6/2017 07:41 | DrB, thanks for the correction regarding $/£. | rcturner2 | |
03/6/2017 15:09 | I bought into this. | petewy |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions